No abstract available
MeSH terms
-
Adolescent
-
Antibodies, Bispecific / therapeutic use*
-
Child
-
Hematopoietic Stem Cell Transplantation / adverse effects*
-
Humans
-
Lymphocyte Activation*
-
Male
-
Neoplasm, Residual
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology
-
Recurrence
-
T-Lymphocytes / immunology*
-
Tissue Donors*
Substances
-
Antibodies, Bispecific
-
blinatumomab